TITLE:
Phase I Study of PEG-Paclitaxel In Patients With Advanced Solid Tumors & Lymphomas

CONDITION:
Neoplasm

INTERVENTION:
PEG-paclitaxel

SUMMARY:

      Studies of PEG-paclitaxel have been terminated
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        None - Study has been terminated.
      
